ACE2 activation for treatment of heart, lung and kidney disease and hypertension
AssigneeApeiron Biologics AG
InventorsJoseph Penninger, Michael A. Crackower
Life of this patent
Estimating the term…
Abstract
ACE2 activating compounds for prevention and treatment of cardiovascular disease, kidney disease, lung disease and hypertension are disclosed. Also disclosed are methods of diagnosing cardiovascular disease, kidney disease, lung disease and hypertension by measuring ACE2 expression or nucleotide polymorphism analysis.
Claims4
A method of treating acute lung injury in a human patient comprising administering an effective amount of an active human ACE2 polypeptide to a human patient.
A method of treating acute lung injury in a human patient comprising administering a composition in soluble form comprising an effective amount of an active human ACE2 polypeptide to a human patient.
Dependencies are inferred from the claim text.